Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Leukemia

Free Subscription Articles published in Biochem Pharmacol Retrieve available abstracts of 13 articles: HTML format

Single Articles

March 2025
1. SUN X, Zhang C, Fan B, Liu Q, et al
   Cotargeting of thioredoxin 1 and glutamate-cysteine ligase in both imatinib-sensitive and imatinib-resistant CML cells.
   Biochem Pharmacol. 2025;233:116763.
   PubMed     Abstract available
   
   
   January 2025
2. HAN YU P, Yan Zhang Z, Yuan Kang Y, Huang P, et al
   Acute myeloid leukemia with t(8;21) translocation: Molecular pathogenesis, potential therapeutics and future directions.
   Biochem Pharmacol. 2025;233:116774.
   PubMed     Abstract available
   
   
   November 2024
3. LIU W, Dou C, Zhang C, Chen P, et al
   PX-478 induces apoptosis in acute myeloid leukemia under hypoxia by inhibiting the PI3K/AKT/mTOR pathway through downregulation of GBE1.
   Biochem Pharmacol. 2024 Nov 9:116620. doi: 10.1016/j.bcp.2024.116620.
   PubMed     Abstract available
   
   
   October 2024
4. ZHAO J, Wu S, Wang D, Edwards H, et al
   Panobinostat sensitizes AraC-resistant AML cells to the combination of azacitidine and venetoclax.
   Biochem Pharmacol. 2024;228:116065.
   PubMed     Abstract available
   
   
   
5. XIE N, Zhong L, Liu L, Fang Y, et al
   Corrigendum to "Autophagy contributes to dasatinib-induced myeloid differentiation of human acute myeloid leukemia cells" [Biochem. Pharmacol. 89/1 (2014) 74-85].
   Biochem Pharmacol. 2024;230.
   PubMed    
   
   
   June 2024
6. CHIOU JT, Lee YC, Huang CH, Wang LJ, et al
   Corrigendum to "Inhibition of Sp1-mediated survivin and MCL1 expression cooperates with SLC35F2 and myeloperoxidase to modulate YM155 cytotoxicity to human leukemia cells" [Biochem. Pharmacol.188 (2021) 114544].
   Biochem Pharmacol. 2024;226:116359.
   PubMed    
   
   
   May 2024
7. SUN L, Rao S, Kerim K, Lu J, et al
   A chemically adjustable BMP6-IL6 axis in mesenchymal stem cells drives acute myeloid leukemia cell differentiation.
   Biochem Pharmacol. 2024;225:116262.
   PubMed     Abstract available
   
   
   April 2024
8. CHIOU JT, Chang LS
   ONC212 enhances YM155 cytotoxicity by triggering SLC35F2 expression and NOXA-dependent MCL1 degradation in acute myeloid leukemia cells.
   Biochem Pharmacol. 2024;224:116242.
   PubMed     Abstract available
   
   
   March 2024
9. DI GIORGIO C, Morretta E, Lupia A, Bellini R, et al
   Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis.
   Biochem Pharmacol. 2024;223:116134.
   PubMed     Abstract available
   
   
   February 2024
10. HURRISH KH, Su Y, Patel S, Ramage CL, et al
    Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro.
    Biochem Pharmacol. 2024;220:115981.
    PubMed     Abstract available
    
    
    November 2023
11. CHIOU JT, Lee YC, Chang LS
    Hydroquinone-selected chronic myelogenous leukemia cells are sensitive to chloroquine-induced cytotoxicity via MCL1 suppression and glycolysis inhibition.
    Biochem Pharmacol. 2023 Nov 19:115934. doi: 10.1016/j.bcp.2023.115934.
    PubMed     Abstract available
    
    
    October 2023
12. HAN H, Zhao C, Liu M, Zhu H, et al
    Mitochondrial complex I inhibition by homoharringtonine: A novel strategy for suppression of chronic myeloid leukemia.
    Biochem Pharmacol. 2023 Oct 21:115875. doi: 10.1016/j.bcp.2023.115875.
    PubMed     Abstract available
    
    
    September 2023
13. OIKONOMOU A, Valsecchi L, Quadri M, Watrin T, et al
    High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia.
    Biochem Pharmacol. 2023 Sep 15:115809. doi: 10.1016/j.bcp.2023.115809.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.